Cap thickness
Showing 1 - 25 of 3,140
Myopia Trial in Seoul (SMILE using 120µm cap thickness, SMILE using 140µm cap thickness)
Completed
- Myopia
- SMILE using 120μm cap thickness
- SMILE using 140μm cap thickness
-
Seoul, Korea, Republic ofDepartment of Ophthalmology, Yonsei Univeristy College of Medici
Oct 15, 2020
Refractive Errors, Myopic Astigmatism Trial in Cairo (Small Incision Lenticule Extraction (SMILE))
Recruiting
- Refractive Errors
- Myopic Astigmatism
- Small Incision Lenticule Extraction (SMILE)
-
Cairo, EgyptAl Watany Eye Hospital
Sep 25, 2023
Acute Coronary Syndrome, Atherosclerosis, Inflammation Trial in Bologna (coronary OCT, 68GaDOTATATE PET/CTCA)
Recruiting
- Acute Coronary Syndrome
- +3 more
- coronary OCT
- 68GaDOTATATE PET/CTCA
-
Bologna, ItalyUniversity of Bologna IRCCS Policlinico di St. Orsola
Jun 27, 2022
Non-culprit Coronary Artery Disease After a Heart Attack
Not yet recruiting
- Coronary Artery Disease
- +2 more
- Optical coherence tomography and pressure wire assessment
- Cardiac magnetic resonance angiogram
- (no location specified)
Mar 21, 2023
Non-Alcoholic Fatty Liver Disease, Obesity Trial in Ras Al Khaimah (POSE2.0 procedure, Life style and behavioral intervention)
Completed
- Non-Alcoholic Fatty Liver Disease
- Obesity
- POSE2.0 procedure
- Life style and behavioral intervention
-
Ras Al Khaimah, United Arab EmiratesObaidulla Hospital, Emirates Health Services, Ministry of Health
Nov 3, 2022
Neuroendocrine Tumors Trial in Hyderabad (Endoscopic submucosal dissection, EFTR)
Recruiting
- Neuroendocrine Tumors
- Endoscopic submucosal dissection
- EFTR
-
Hyderabad, Telangana, IndiaAsian institute of Gastroenterology
Nov 11, 2023
Colorectal Tumors Trial in Ariccia (Endoscopic Full-Thickness Resection (EFTR), Endoscopic Submucosal Dissection (ESD))
Active, not recruiting
- Colorectal Neoplasms
- Endoscopic Full-Thickness Resection (EFTR)
- Endoscopic Submucosal Dissection (ESD)
-
Ariccia, Rome, ItalyOspedale Dei Castelli
Aug 12, 2022
Atherosclerosis Trial in Beijing (68Ga-FAPI)
Recruiting
- Atherosclerosis
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 6, 2021
Acute Coronary Syndrome Trial in Copenhagen, Roskilde, Lund (CTS Device)
Recruiting
- Acute Coronary Syndrome
- CTS Device
-
Copenhagen, Denmark
- +2 more
Nov 4, 2022
Coronary Artery Disease (CAD) Trial in Worldwide (Evolocumab, Placebo, Statin therapy)
Completed
- Coronary Artery Disease (CAD)
- Evolocumab
- +2 more
-
Los Angeles, California
- +32 more
Apr 7, 2022
ORA and Residual Refractive Astigmatism After SMILE
Completed
- Refractive Errors
- Astigmatism
- Small Incision Lenticule Extraction
-
Taipei, TaiwanTaipei Nobel Eye Clinic
Oct 31, 2022
Tumor, Breast Trial in Seoul (Scalp cooling system 2)
Completed
- Neoplasm, Breast
- Scalp cooling system 2
-
Seoul, Korea, Republic ofSamsung Medical Center, Ilwon-ro 81, Gangnam-gu
Dec 14, 2022
Natural History of Coronary Atherosclerosis
Not yet recruiting
- Coronary Artery Disease Progression
- +3 more
- (no location specified)
Sep 13, 2023
Coronary Artery Disease Trial in New York (Evolocumab Injections)
Recruiting
- Coronary Artery Disease
- Evolocumab Injections
-
New York, New YorkMount Sinai Hospital
May 13, 2021
Rosuvastatin and Evolocumab for Coronary Artery Disease
Completed
- Coronary Artery Disease
-
New York, New YorkMount Sinai Hospital
Aug 2, 2023
Atherosclerotic Cardiovascular Disease Trial in Beijing (Naoxintong Capsule, Placebo)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Naoxintong Capsule
- Placebo
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences, Fuwai Hospital
May 18, 2022
The Carotid Artery Multi-modality Imaging Prognostic Study
Recruiting
- Carotid Artery Diseases
- +2 more
-
Pisa, Tuscany, ItalyAzienda Ospedaliero Universitaria Pisana
Nov 6, 2022
Diabetes, Type 2 Trial in Austria, Denmark, Sweden (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Graz, Austria
- +3 more
Dec 5, 2022
Hyperopia, High Astigmatism Trial in Pristina (Fresh Corneal Lenticule Implantation using Relex-Smile VisuMax Femtosecond Laser)
Active, not recruiting
- Hyperopia
- High Astigmatism
- Fresh Corneal Lenticule Implantation using Relex-Smile VisuMax Femtosecond Laser
-
Pristina, KosovoEye Hospital Pristina
Jul 26, 2022
Progressive Disease of Corneae Trial in Pristina (ReLex-smile)
Enrolling by invitation
- Progressive Disease of Corneae
- ReLex-smile
-
Pristina, KosovoEye Hospital Pristina
Mar 21, 2022
Cerebral Atherosclerosis Trial (Evolocumab 140 MG/ML, Intensive statin treatment)
Not yet recruiting
- Cerebral Atherosclerosis
- Evolocumab 140 MG/ML
- Intensive statin treatment
- (no location specified)
Oct 15, 2022
Verruca Vulgaris, Molluscum Contagiosum Skin Infection Trial in Charleston (Floating electrode-dielectric barrier device
Recruiting
- Verruca Vulgaris
- Molluscum Contagiosum Skin Infection
- Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Mar 14, 2022
Presbyopia Trial in Pristina (relex Smile module)
Enrolling by invitation
- Presbyopia
- relex Smile module
-
Pristina, KosovoEye Hospital Pristina
Nov 9, 2021
Diabetes, Coronary Artery Disease, Coronary Atheroscleroses Trial in Zwolle (Optical Coherence Tomography)
Completed
- Diabetes Mellitus
- +2 more
- Optical Coherence Tomography
-
Zwolle, Overijssel, NetherlandsIsala
Aug 30, 2021